Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium vs Placebo in Mild COPD (SPIRIMILD)
NCT00144196Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Mar 2004; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00144196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144196.